Suppr超能文献

人降钙素受体丰富亚型的克隆与特性分析

Cloning and characterization of an abundant subtype of the human calcitonin receptor.

作者信息

Kuestner R E, Elrod R D, Grant F J, Hagen F S, Kuijper J L, Matthewes S L, O'Hara P J, Sheppard P O, Stroop S D, Thompson D L

机构信息

ZymoGenetics Inc., Seattle, Washington 98102.

出版信息

Mol Pharmacol. 1994 Aug;46(2):246-55.

PMID:8078488
Abstract

We have cloned and characterized a second form of the human calcitonin receptor from T47D cells. It resembles the clone described by Gorn et al. [J. Clin. Invest. 90:1726-1735 (1992)] except that it lacks a 16-amino acid insert in the putative first intracellular loop. The insert-negative receptor appears to be the most abundant form, and it occurs at a relatively constant level in all expressing tissues. In contrast, the insert-positive receptor is found at low levels in most tissues but its expression levels appear to be much more variable. The insert-negative cDNA was stably expressed in baby hamster kidney cells. Like the endogenous T47D receptor, the recombinant receptor has an equally high affinity for salmon and porcine calcitonin but a 3-4-fold lower affinity for human calcitonin. High concentrations of calcitonin gene-related peptide, rat amylin, secretin, or vasoactive intestinal peptide do not significantly compete with calcitonin for binding to the recombinant receptor. Calcitonin stimulates a cAMP response in both T47D and transfected baby hamster kidney cells. Salmon calcitonin is more potent than human calcitonin for T47D cells, but the two are nearly equipotent for the transfectants. Furthermore, the ED50 for the cAMP response in the transfectants is 10-100-fold lower than in T47D cells. Calcitonin stimulates inositol phosphate turnover and elevates internal calcium levels in the transfectants. This response requires non-physiological levels of calcitonin and is directly correlated with the number of receptors. Lastly, by using a human/rodent somatic cell hybrid panel and in situ hybridization, we localized the human calcitonin receptor gene to chromosome 7.

摘要

我们从T47D细胞中克隆并鉴定了人降钙素受体的第二种形式。它类似于Gorn等人[《临床研究杂志》90:1726 - 1735(1992)]所描述的克隆体,只是在假定的第一个细胞内环中缺少一个16个氨基酸的插入片段。插入片段缺失的受体似乎是最丰富的形式,并且在所有表达组织中以相对恒定的水平出现。相比之下,插入片段存在的受体在大多数组织中含量较低,但其表达水平似乎变化更大。插入片段缺失的cDNA在幼仓鼠肾细胞中稳定表达。与内源性T47D受体一样,重组受体对鲑鱼降钙素和猪降钙素具有同样高的亲和力,但对人降钙素的亲和力低3 - 4倍。高浓度的降钙素基因相关肽、大鼠胰岛淀粉样多肽、促胰液素或血管活性肠肽与降钙素竞争结合重组受体时,不会产生显著竞争。降钙素在T47D细胞和转染的幼仓鼠肾细胞中均刺激cAMP反应。对于T47D细胞,鲑鱼降钙素比人降钙素更有效,但对于转染细胞,两者几乎等效。此外,转染细胞中cAMP反应所需的半数有效剂量(ED50)比T47D细胞低10 - 100倍。降钙素刺激转染细胞中的肌醇磷酸周转并提高细胞内钙水平。这种反应需要非生理水平的降钙素,并且与受体数量直接相关。最后,通过使用人/啮齿动物体细胞杂交板和原位杂交技术,我们将人降钙素受体基因定位到了7号染色体上。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验